SCHEMBL10146101

SCHEMBL10146101

CC(C)(C)C(C)(C)S(=O)(=O)Cc1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.38
DPP4 P27487 1/20 0.37
KDM4E B2RXH2 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
RIPK1 Q13546 2/20 0.36
KCNA5 P22460 1/20 0.36
IDO1 P14902 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35
POLB P06746 1/20 0.35
APEX1 P27695 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TAAR1 Q96RJ0 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10147479 0.84 L3MBTL1 (0.43) L3MBTL1ALDH1A1KMT2AHPGDDPP4
SCHEMBL14227522 0.81 L3MBTL1 (0.44) L3MBTL1ALDH1A1KMT2AKDM4EBCHE
SCHEMBL777188 0.73 KMT2A (0.44) L3MBTL1KMT2ABCHEACHEIDO1
SCHEMBL422010 0.72 USP2 (0.51) L3MBTL1ALDH1A1KMT2AIDO1LOXL2
SCHEMBL24429451 0.72 KMT2A (0.49) L3MBTL1ALDH1A1KMT2AHPGDKDM4E
SCHEMBL351585 0.72 HPGD (0.41) ALDH1A1KMT2AHPGDDPP4KDM4E
SCHEMBL775451 0.71 LMNA (0.44) L3MBTL1KMT2ABCHEACHEIDO1
SCHEMBL351784 0.71 MAPT (0.44) L3MBTL1ALDH1A1KMT2AHPGDKDM4E
SCHEMBL9421733 0.70 FAAH (0.62) L3MBTL1KMT2ABCHEACHEKCNA5
SCHEMBL10146079 0.69 ALDH1A1 (0.47) ALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120015988-A1 Sulfone Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015988-A1 Sulfone Compounds Which Modulate The CB2 Receptor CNR2, CNR1, TRPV1 L3MBTL1 4584/4885ALDH1A1 2844/4885KMT2A 3160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.